AUDENTES THERAPEUTICS, INC. enters TAYSHA GENE THERAPIES, INC. with 7.27M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 10/31/2022ACC: 0000899243-22-034545
10% Owner
Since Oct 2022
7.27M
Baseline shares
100% direct
7.27M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned7.27M
Total
7.27M direct7.27M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 7.27M | Direct |
| Total | 7.27M | 7.27M direct |
Derivative Holdings0
No derivative holdings reported